Marshall Wace, LLP Balchem Corp Transaction History

Marshall Wace, LLP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$138.5 - $156.63 $808,009 - $913,779	5,834 New	5,834 $898,000
Q3 2023 Nov 14, 2023	BUY	$123.38 - $142.72 $259,098 - $299,712	2,100 New	2,100 $260,000
Q1 2022 May 16, 2022	SELL	$131.21 - $167.55 $138,820 - $177,267	-1,058 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$149.18 - $172.5 $157,832 - $182,505	1,058 New	1,058 $179,000
Q2 2021 Aug 13, 2021	SELL	$119.87 - $133.92 $334,437 - $373,636	-2,790 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$107.03 - $131.53 $3.27 Million - $4.02 Million	-30,560 Reduced 91.63%	2,790 $350,000
Q4 2020 Feb 16, 2021	SELL	$98.58 - $115.22 $9.68 Million - $11.3 Million	-98,203 Reduced 74.65%	33,350 $3.84 Million
Q3 2020 Nov 16, 2020	BUY	$91.61 - $103.46 $10.3 Million - $11.6 Million	112,358 Added 585.35%	131,553 $12.8 Million
Q2 2020 Aug 13, 2020	BUY	$80.3 - $102.54 $1.42 Million - $1.81 Million	17,679 Added 1166.16%	19,195 $1.82 Million
Q1 2020 May 15, 2020	BUY	$81.49 - $113.6 $123,538 - $172,217	1,516 New	1,516 $150,000

374

28.2M

267K

5.7K

Ticker BCPC
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 32,120,600
Market Cap $5.09B
Description
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal N...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.